Life Technologies Corp (LIFE) [Rocket]

In millions, except per share items	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09	Dec-31-08	Dec-31-07	Dec-31-06	Dec-31-05
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
BioDiscovery							814.7	732.0
Cell Systems							336.5	347.1
Total revenues	3,798.5	3,775.7	3,588.1	3,280.3	1,620.3	1,281.7	1,151.2	1,079.1
Revenue growth [+]	0.6%	5.2%	9.4%	102.5%	26.4%	11.3%	6.7%	5.4%
BioDiscovery							11.3%	23.8%
Cell Systems							-3.0%	-19.7%
Cost of goods sold	1,372.3	1,357.0	1,188.2	1,173.1	592.7	467.1	432.2	419.2
Gross profit	2,426.2	2,418.7	2,399.9	2,107.3	1,027.6	814.6	719.0	659.9
Gross margin	63.9%	64.1%	66.9%	64.2%	63.4%	63.6%	62.5%	61.2%
Selling, general and administrative [+]	1,054.6	1,009.0	1,023.2	987.1	499.3	416.1	382.5	321.8
Sales and marketing							232.4	204.0
General and administrative							150.1	117.8
Research and development	341.9	377.9	375.5	337.1	142.5	115.8	104.3	97.8
Other operating expenses	290.3	308.7	293.8	282.6	86.9	98.7	110.7	110.4
EBITDA [+]	1,168.3	1,160.6	1,130.1	912.2	431.5	320.0	283.3	287.6
EBITDA growth	0.7%	2.7%	23.9%	111.4%	34.8%	13.0%	-1.5%	1.4%
EBITDA margin	30.8%	30.7%	31.5%	27.8%	26.6%	25.0%	24.6%	26.7%
Depreciation	126.0	123.6	123.0	115.7	45.7	37.4	41.2	38.7
EBITA	1,042.3	1,037.0	1,007.1	796.5	385.8	282.7	242.1	248.9
EBITA margin	27.4%	27.5%	28.1%	24.3%	23.8%	22.1%	21.0%	23.1%
Amortization of intangibles	302.9	313.9	299.6	296.0	86.9	98.7	120.6	118.9
EBIT [+]	739.4	723.1	707.5	500.5	298.9	184.0	121.5	130.0
EBIT growth	2.3%	2.2%	41.4%	67.4%	62.5%	51.4%	-6.5%	-4.8%
EBIT margin	19.5%	19.2%	19.7%	15.3%	18.4%	14.4%	10.6%	12.0%
Non-recurring items [+]	74.2	75.3	95.1	114.6	131.9	5.6	12.5	17.5
Restructuring charges	72.7	75.3	93.5	112.9	38.6
In-process research & development			1.7	1.7	93.3
Interest expense, net [+]	121.5	158.1	148.1	188.2	60.5	39.5	5.5	9.4
Interest expense	123.9	162.1	152.3	192.9	85.1	67.4	32.2	34.0
Interest income	2.4	3.9	4.3	4.7	24.6	28.0	26.7	24.6
Other income (expense), net [+]	-11.9	-10.9	-22.8	-3.1	5.7	0.3	0.5	56.4
Gain (loss) on debt retirement			-54.2	-12.5
Other	-11.9	-10.9	-5.9	9.4	5.7
Pre-tax income	531.8	478.7	441.6	194.5	112.2	139.2	104.1	159.5
Income taxes	101.4	100.9	63.7	50.0	107.9	33.0	28.3	38.1
Tax rate	19.1%	21.1%	14.4%	25.7%	96.1%	23.7%	27.2%	23.9%
Minority interest	0.4	0.7	0.4
Earnings from continuing ops	430.9	378.5	378.3	144.6	4.4	106.2	75.8	121.5
Earnings from discontinued ops					1.4	12.9	-266.8	10.6
Net income	430.9	378.5	378.3	144.6	5.7	119.1	-191.0	132.0
Net margin	11.3%	10.0%	10.5%	4.4%	0.4%	9.3%	-16.6%	12.2%

Basic EPS [+]	$2.45	$2.11	$2.06	$0.82	$0.04	$1.14	$737.06	$2.33
Growth	16.1%	2.3%	150.9%	1772.9%	-96.1%	-99.8%	31593.1%	35.3%
Diluted EPS [+]	$2.40	$2.04	$1.98	$0.80	$0.04	$1.09	$716.57	$2.02
Growth	17.8%	2.7%	149.0%	1797.2%	-96.2%	-99.8%	35299.0%	37.6%

Shares outstanding (basic) [+]	175.8	179.4	183.4	175.9	99.2	93.4	0.1	52.2
Growth	-2.0%	-2.2%	4.3%	77.2%	6.3%	90741.2%	-99.8%	1.1%
Shares outstanding (diluted) [+]	179.4	185.6	190.6	181.4	103.7	97.1	0.1	60.0
Growth	-3.4%	-2.6%	5.1%	75.0%	6.7%	91788.3%	-99.8%	-0.6%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.